Scientist, Bioanalytical - San Diego, CA jobs in United States
cer-icon
Apply on Employer Site
company-logo

Mirador Therapeutics · 7 hours ago

Scientist, Bioanalytical - San Diego, CA

Mirador Therapeutics is a next-generation precision medicine company focused on immunology and inflammation. They are seeking a motivated Scientist to join the Bioanalytical Team, focusing on PK, immunogenicity, and cell-based assays to support biologics drug candidates.

Health CareMedicalTherapeutics
check
H1B Sponsor Likelynote

Responsibilities

This lab-based position will conceptualize and perform PK, immunogenicity, and cell-based assays including but not limited to support detection of Anti-Drug Antibodies (ADAs), use of Idiotypic antibodies for PK/ADA assays, ligand-binding and neutralization assays in both the regulated and non-regulated environment to support biologics drug candidates (monoclonal and bispecific antibodies) in pre-clinical and clinical development
Conduct lab work and collaborate with CROs and CMOs to develop, validate, and execute bioanalytical and cell-based potency assays, as well as interpret and report results to support drug discovery and clinical development activities
Collaborate internally with immunology, protein engineering, CMC, clinical development teams, and work closely with multiple external contract organizations including contract laboratories and CMOs in the areas of method transfer, qualification/validation and implementation of QC methods

Qualification

Bioanalytical assay developmentMethod development/qualification/validationImmunoassay technologiesCollaboration with CROsGLP/GCPAnalytical skillsProblem-solving skillsOrganizational skillsInterpersonal skillsCommunication skills

Required

Bachelor's degree in biology/biochemistry or related discipline
8 or more years of biotechnology/pharmaceutical industry experience in bioanalytical assay development or Master's degree with 6 or more years of relevant
Knowledge and hands-on experience with method development, qualification, and validation of cell-based bioassays for potency measurement to support GMP manufacturing, product characterization, lot release, and stability testing are required
Experience collaborating with CROs
Strong knowledge of immunoassay (plate-based and cell-based assay) development, execution and troubleshooting, as well as hands-on experience in immunoassay technologies, such as ELISA (direct and indirect sandwich formats), Luminescence, Colorimetric, Electrochemiluminescence (MSD), etc. to support preclinical and clinical studies
Independent, self-motivated life scientist with the ability to generate scientific questions and design experiments to address them
Excellent problem-solving, analytical and organizational skills
Strong interpersonal and communication skills including presenting data to all levels of the organization
Understanding of global health authority expectations in bioanalytical space for biologics drug development and registration in immunology/inflammation therapeutic area
Demonstrates scientific rigor and curiosity to address scientific questions and design experiments to test a working hypothesis
Ability to work in a fast-paced and matrix environment to meet project deadlines

Preferred

Familiarity with GLP, GCP, Bioanalytical and Immunogenicity Guidance (FDA/EMA) is desirable

Benefits

Bonus
Equity
Comprehensive benefits

Company

Mirador Therapeutics

twittertwitter
company-logo
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases.

H1B Sponsorship

Mirador Therapeutics has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)

Funding

Current Stage
Early Stage
Total Funding
$480M
Key Investors
ARCH Venture Partners
2024-04-03Series Unknown· $80M
2024-03-21Series A· $400M
2024-03-19Debt Financing
Company data provided by crunchbase